Yin Shanshan, Zhang Chao, Gao Fenghou
Department of Oncology, Shanghai 9th People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Department of Geriatrics, Shanghai 9th People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Transl Cancer Res. 2022 Jul;11(7):2388-2397. doi: 10.21037/tcr-22-1759.
promotes the occurrence of lymphoma and is also related to the development of breast cancer, liver cancer, and ovarian cancer. It was hypothesized that influences tertiary lymphoid structures (TLSs) formation and development in the tumor immune microenvironment, and this effect of on the tumor immune microenvironment has not been explored. Using melanoma grafts as a model, we investigated the effect of on the immune microenvironment of melanoma.
The Cell Count Kit-8 (CCK8) assay was used to detect the effect overexpression in melanoma cells on cell proliferation. The overexpression vector was constructed by homologous recombination. After linearization, the overexpression vector was microinjected into the fertilized egg. Transgenic mice overexpressing were screened by tail identification. After melanoma B16 mouse cells were digested into single cells, the tumor was subcutaneously implanted in C57BL6/J-wild type (WT) mice and transgenic mice, and the tumor growth of the 2 groups was compared. The number of TLSs in the tumor tissues of mice was analyzed after hematoxylin-eosin (HE) staining.
Overexpression of in melanoma cells did not affect cell proliferation. The overexpression vector pcDNA3.1-CAG-IKAROS was successfully constructed. Viable fertilized eggs were obtained after microinjection. Transgenic mice stably expressing were identified by polymerase chain reaction (PCR). Compared with WT mice, the tumor load of transgenic mice increased significantly. HE staining showed that the number of immature TLSs in melanomas of transgenic mice increased significantly.
does not affect the proliferation of melanoma cells. Transgenic mice overexpressing were successfully constructed. is a key driver gene of the formation of immature TLS.
促进淋巴瘤的发生,还与乳腺癌、肝癌和卵巢癌的发展有关。据推测,其影响肿瘤免疫微环境中三级淋巴结构(TLSs)的形成和发展,且尚未探究其对肿瘤免疫微环境的这种作用。以黑色素瘤移植瘤为模型,我们研究了其对黑色素瘤免疫微环境的影响。
采用细胞计数试剂盒-8(CCK8)检测法来检测黑色素瘤细胞中其过表达对细胞增殖的影响。通过同源重组构建其过表达载体。线性化后,将过表达载体显微注射到受精卵中。通过尾部鉴定筛选出过表达的转基因小鼠。将黑色素瘤B16小鼠细胞消化成单细胞后,皮下接种到C57BL6/J野生型(WT)小鼠和转基因小鼠体内,比较两组的肿瘤生长情况。苏木精-伊红(HE)染色后分析小鼠肿瘤组织中TLSs的数量。
黑色素瘤细胞中其过表达不影响细胞增殖。成功构建了其过表达载体pcDNA3.1-CAG-IKAROS。显微注射后获得了存活的受精卵。通过聚合酶链反应(PCR)鉴定出稳定表达的转基因小鼠。与WT小鼠相比,转基因小鼠的肿瘤负荷显著增加。HE染色显示,转基因小鼠黑色素瘤中未成熟TLSs的数量显著增加。
不影响黑色素瘤细胞的增殖。成功构建了过表达的转基因小鼠。是未成熟TLS形成的关键驱动基因。